A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer

File(s)

A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer.pdf (1.07 MB)

Accepted version

Show more

Author(s)

Gulliford, T

English, J

Colston, KW

Menday, P

Moller, S

more

Type

Journal Article

Date Issued

1998-07-01

URI

http://hdl.handle.net/10044/1/53542

DOI

https://dx.doi.org/10.1038/bjc.1998.434

ISSN

0007-0920

Publisher

CHURCHILL LIVINGSTONE

Start Page

6

End Page

13

Journal / Book Title

BRITISH JOURNAL OF CANCER

Volume

78

Issue

1

Copyright Statement

Creative Commons Attribution Non-Commercial Share Alike License

Identifier

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000074294400002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Subjects

Science & Technology

Life Sciences & Biomedicine

Oncology

ONCOLOGY

calcitriol

cancer therapy

differentiation agents

LEUKEMIC-CELL GROWTH

1,25-DIHYDROXYVITAMIN-D3

DIFFERENTIATION

INVIVO

1-ALPHA,25-DIHYDROXYVITAMIN-D3

CALCIPOTRIOL

COMBINATION

INHIBITION

PSORIASIS

HORMONE

Adult

Aged

Antineoplastic Agents

Breast Neoplasms

Calcitriol

Calcium, Dietary

Colonic Neoplasms

Dose-Response Relationship, Drug

Female

Humans

Hypercalcemia

Male

Middle Aged

1112 Oncology And Carcinogenesis

Oncology & Carcinogenesis

Publication Status

Published